Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2006

01.12.2006

The Restorative Effect of Taurine on Experimental Nonalcoholic Steatohepatitis

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2006

Einloggen, um Zugang zu erhalten

Abstract

Our objective was to explore the restorative effect of taurine on experimental nonalcoholic steatohepatitis (NASH). Thirty-six SD rats were randomly divided into three groups, 12 in each group: the normal group was fed standard rat diet; the model group and the treatment group were both fed a high-fat rat diet for 12 weeks, and the rats in the treatment group were simultaneously injected with taurine subcutaneously for 8 weeks. Hepatic histological change was observed; TNF-α and TGF-β1 protein expression was identified by immunohistochemistry; mRNA expression of TNF-α, TGF-β1, type I procollagen, and adiponectin was measured by RT-PCR; body weight, weight gain, liver weight, and liver index were measured; and biochemical parameters monitored included serum transaminases, serum lipids, fasting plasma glucose, and hepatic level of oxidative stress. Rats in the model group showed a significant increase in liver weight, liver index, serum transaminase activities, serum triglyceride, fasting plasma glucose, and oxidative stress; the mRNA expression of TNF-α, TGF-β1, and type I procollagen increased, whereas the expression of adiponectin decreased significantly, compared with that in the normal group. The typical hepatic lesions of NASH were observed histologically in the model group. Taurine treatment resulted in a significant decrease in liver weight, liver index, serum transaminase activities, serum triglyceride, fasting plasma glucose, and oxidative stress; the mRNA expression of TNF-α, TGF-β1, and type I procollagen decreased, but the expression of adiponectin increased significantly, compared with that in the model group. Histological improvement was observed in the treatment group. In conclusion, taurine could inhibit lipid peroxidation, improve lipid and glucose metabolism, decrease synthesis of TNF-α and TGF-β1, promote synthesis of adiponectin, and have a restorative effect on experimental NASH.
Literatur
1.
Zurück zum Zitat Day CP, James OFW (1998) Steatohepatitis: A tale of two “hits”? Gastroenterology 114:842–845CrossRefPubMed Day CP, James OFW (1998) Steatohepatitis: A tale of two “hits”? Gastroenterology 114:842–845CrossRefPubMed
2.
Zurück zum Zitat Lefkowitch JH, Haythe JH, Regent N (2002) Kupffer cell aggregation and perivenular distribution in steatohepatitis. Mod Pathol 15:699–704CrossRefPubMed Lefkowitch JH, Haythe JH, Regent N (2002) Kupffer cell aggregation and perivenular distribution in steatohepatitis. Mod Pathol 15:699–704CrossRefPubMed
3.
Zurück zum Zitat Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40:46–54CrossRefPubMed Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40:46–54CrossRefPubMed
4.
Zurück zum Zitat Lee KS, Buck M, Houglum K, Chojkier M (1995) Activation of hepatic stellate cells by TGF alpha and collagen type l is mediated by oxidative stress through c–myb expression. J Clin Invest 96:2461–2468PubMed Lee KS, Buck M, Houglum K, Chojkier M (1995) Activation of hepatic stellate cells by TGF alpha and collagen type l is mediated by oxidative stress through c–myb expression. J Clin Invest 96:2461–2468PubMed
5.
Zurück zum Zitat Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953CrossRefPubMed Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953CrossRefPubMed
6.
Zurück zum Zitat Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose–derived protein Acrp30. J Clin Invest 108:1875–1881CrossRefPubMed Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose–derived protein Acrp30. J Clin Invest 108:1875–1881CrossRefPubMed
7.
Zurück zum Zitat Rajala MW, Scherer PE (2003) Minireview: the adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765–3773CrossRefPubMed Rajala MW, Scherer PE (2003) Minireview: the adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765–3773CrossRefPubMed
8.
Zurück zum Zitat Obinata K, Maruyama T, Hayashi M, Watanabe T, Nittono H (1996) Effect of taurine on the fatty liver of children with simple obesity. Adv Exp Med Biol 403:607–613PubMed Obinata K, Maruyama T, Hayashi M, Watanabe T, Nittono H (1996) Effect of taurine on the fatty liver of children with simple obesity. Adv Exp Med Biol 403:607–613PubMed
9.
Zurück zum Zitat Chen YX, Liu S, Zeng X, Xie WF (2005) A pilot study of the effect of taurine on patients with nonalcoholic fatty liver. Chin J Pract Intern Med 25:249–250 Chen YX, Liu S, Zeng X, Xie WF (2005) A pilot study of the effect of taurine on patients with nonalcoholic fatty liver. Chin J Pract Intern Med 25:249–250
10.
Zurück zum Zitat Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413–1419CrossRefPubMed Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413–1419CrossRefPubMed
11.
Zurück zum Zitat Nouchi T, Worner TM, Sato S, Lieber CS (1987) Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease. Alcohol Clin Exp Res 11:287–291CrossRefPubMed Nouchi T, Worner TM, Sato S, Lieber CS (1987) Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease. Alcohol Clin Exp Res 11:287–291CrossRefPubMed
12.
Zurück zum Zitat Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474CrossRefPubMed Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474CrossRefPubMed
13.
Zurück zum Zitat Nanji AA (2004) Animal models of nonalcoholic fatty liver disease and steatohepatitis. Clin Liver Dis 8:559–574, ixCrossRefPubMed Nanji AA (2004) Animal models of nonalcoholic fatty liver disease and steatohepatitis. Clin Liver Dis 8:559–574, ixCrossRefPubMed
14.
Zurück zum Zitat Lieber CS, Leo MA, Mak KM, et al. (2004) Model of nonalcoholic steatohepatitis. Am J Clin Nutr 79:502–509PubMed Lieber CS, Leo MA, Mak KM, et al. (2004) Model of nonalcoholic steatohepatitis. Am J Clin Nutr 79:502–509PubMed
15.
Zurück zum Zitat Yan CC, Bravo E, Cantafora A (1993) Effect of taurine levels on liver lipid metabolism: an in vivo study in the rat. Proc Soc Exp Biol Med 202:88–96PubMed Yan CC, Bravo E, Cantafora A (1993) Effect of taurine levels on liver lipid metabolism: an in vivo study in the rat. Proc Soc Exp Biol Med 202:88–96PubMed
16.
Zurück zum Zitat Balkan J, Kanbagli O, Aykac-Toker G, Uysal M (2002) Taurine treatment reduces hepatic lipids and oxidative stress in chronically ethanol-treated rats. Biol Pharm Bull 25:1231–1233CrossRefPubMed Balkan J, Kanbagli O, Aykac-Toker G, Uysal M (2002) Taurine treatment reduces hepatic lipids and oxidative stress in chronically ethanol-treated rats. Biol Pharm Bull 25:1231–1233CrossRefPubMed
17.
Zurück zum Zitat No authors listed (1993) Age-associated loss of carrier-mediated intestinal taurine transport in cats. Nutr Rev 51:22–23 No authors listed (1993) Age-associated loss of carrier-mediated intestinal taurine transport in cats. Nutr Rev 51:22–23
18.
Zurück zum Zitat No authors listed (2001) Taurine-monograph. Altern Med Rev 6:78–82 No authors listed (2001) Taurine-monograph. Altern Med Rev 6:78–82
19.
Zurück zum Zitat Chen YX, Wang SC, Zhao GN, et al. (1992) Membrane stabilization action of taurine on rat hepatic lysosomes. J Fourth Milit Med Univ 13:221–222 Chen YX, Wang SC, Zhao GN, et al. (1992) Membrane stabilization action of taurine on rat hepatic lysosomes. J Fourth Milit Med Univ 13:221–222
20.
Zurück zum Zitat Chen YX, Wang SC, Zhao GN, et al. (1992) Effect of taurine on calcium uptake and release by isolated rat liver mitochondria. J Fourth Milit Med Univ 13:282–283 Chen YX, Wang SC, Zhao GN, et al. (1992) Effect of taurine on calcium uptake and release by isolated rat liver mitochondria. J Fourth Milit Med Univ 13:282–283
21.
Zurück zum Zitat Kozumbo WJ, Agarwal S, Koren HS (1992) Breakage and binding of DNA by reaction products of hypochlorous acid with aniline, l-naphthylamine or l-naphthol. Toxicol Appl Pharmacol 115:107–115CrossRefPubMed Kozumbo WJ, Agarwal S, Koren HS (1992) Breakage and binding of DNA by reaction products of hypochlorous acid with aniline, l-naphthylamine or l-naphthol. Toxicol Appl Pharmacol 115:107–115CrossRefPubMed
22.
Zurück zum Zitat Dogru-Abbasoglu S, Kanbagli O, Balkan J, Cevikbas U, Aykac-Toker G, Uysal M (2001) The protective effect of taurine against thioacetamide hepatotoxicity of rats. Hum Exp Toxicol 20:23–27CrossRefPubMed Dogru-Abbasoglu S, Kanbagli O, Balkan J, Cevikbas U, Aykac-Toker G, Uysal M (2001) The protective effect of taurine against thioacetamide hepatotoxicity of rats. Hum Exp Toxicol 20:23–27CrossRefPubMed
23.
Zurück zum Zitat Balkan J, Dogru-Abbasoglu S, Kanbagli O, Cevikbas U, Aykac-Toker G, Uysal M (2001) Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. Hum Exp Toxicol 20:251–254CrossRefPubMed Balkan J, Dogru-Abbasoglu S, Kanbagli O, Cevikbas U, Aykac-Toker G, Uysal M (2001) Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. Hum Exp Toxicol 20:251–254CrossRefPubMed
24.
Zurück zum Zitat Miyazaki T, Karube M, Matsuzaki Y, et al. (2005) Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis. J Hepatol 43:117–125CrossRefPubMed Miyazaki T, Karube M, Matsuzaki Y, et al. (2005) Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis. J Hepatol 43:117–125CrossRefPubMed
25.
Zurück zum Zitat Chen Y, Li S, Zhang X, Zhang Z, Xie W (2002) Amelioration of carbon tetrachloride-induced hepatic fibrosis in rats by treatment with salvia miltiorrhiza and taurine. Zhonghua Gan Zang Bing Za Zhi 10:148–149PubMed Chen Y, Li S, Zhang X, Zhang Z, Xie W (2002) Amelioration of carbon tetrachloride-induced hepatic fibrosis in rats by treatment with salvia miltiorrhiza and taurine. Zhonghua Gan Zang Bing Za Zhi 10:148–149PubMed
26.
Zurück zum Zitat Refik Mas M, Comert B, et al. (2004) The effect of taurine treatment on oxidative stress in experimental liver fibrosis. Hepatol Res 28:207–215CrossRefPubMed Refik Mas M, Comert B, et al. (2004) The effect of taurine treatment on oxidative stress in experimental liver fibrosis. Hepatol Res 28:207–215CrossRefPubMed
27.
Zurück zum Zitat Waters E, Wang JH, Redmond HP, Wu QD, Kay E, Bouchier-Hayes D (2001) Role of taurine in preventing acetaminophen-induced hepatic injury in the rat. Am J Physiol Gastrointest Liver Physiol 280:G1274–G1279PubMed Waters E, Wang JH, Redmond HP, Wu QD, Kay E, Bouchier-Hayes D (2001) Role of taurine in preventing acetaminophen-induced hepatic injury in the rat. Am J Physiol Gastrointest Liver Physiol 280:G1274–G1279PubMed
28.
Zurück zum Zitat Pushpakiran G, Mahalakshmi K, Anuradha CV (2004) Taurine restores ethanol-induced depletion of antioxidants and attenuates oxidative stress in rat tissues. Amino Acids 27:91–96CrossRefPubMed Pushpakiran G, Mahalakshmi K, Anuradha CV (2004) Taurine restores ethanol-induced depletion of antioxidants and attenuates oxidative stress in rat tissues. Amino Acids 27:91–96CrossRefPubMed
29.
Zurück zum Zitat Balkan J, Parldar FH, Dogru-Abbasoglu S, Aykac-Toker G, Uysal M (2005) The effect of taurine or betaine pretreatment on hepatotoxicity and prooxidant status induced by lipopolysaccharide treatment in the liver of rats. Eur J Gastroenterol Hepatol 17:917–921CrossRefPubMed Balkan J, Parldar FH, Dogru-Abbasoglu S, Aykac-Toker G, Uysal M (2005) The effect of taurine or betaine pretreatment on hepatotoxicity and prooxidant status induced by lipopolysaccharide treatment in the liver of rats. Eur J Gastroenterol Hepatol 17:917–921CrossRefPubMed
30.
Zurück zum Zitat Hagar HH (2004) The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol Lett 151:335–343CrossRefPubMed Hagar HH (2004) The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol Lett 151:335–343CrossRefPubMed
31.
Zurück zum Zitat Chen YX (1993) Protective action of taurine on ischemia-reperfusion liver injury in rats and its mechanism. Zhonghua Yi Xue Za Zhi 73:276–279, 318–319PubMed Chen YX (1993) Protective action of taurine on ischemia-reperfusion liver injury in rats and its mechanism. Zhonghua Yi Xue Za Zhi 73:276–279, 318–319PubMed
32.
Zurück zum Zitat Chen YX, Wang SC, Zhao GN, Zhang LZ, Tang J, Tang CS (1992) Effect of taurine on lipid peroxidation of isolated rat hepatocellular plasma membrane. J Fourth Milit Med Univ 13:279–281 Chen YX, Wang SC, Zhao GN, Zhang LZ, Tang J, Tang CS (1992) Effect of taurine on lipid peroxidation of isolated rat hepatocellular plasma membrane. J Fourth Milit Med Univ 13:279–281
33.
Zurück zum Zitat Schuller-Levis GB, Park E (2004) Taurine and its chloramine: modulators of immunity. Neurochem Res 29:117–126CrossRefPubMed Schuller-Levis GB, Park E (2004) Taurine and its chloramine: modulators of immunity. Neurochem Res 29:117–126CrossRefPubMed
34.
Zurück zum Zitat Sethupathy S, Elanchezhiyan C, Vasudevan K, Rajagopal G (2002) Antiatherogenic effect of taurine in high fat diet fed rats. Indian J Exp Biol 40:1169–1172PubMed Sethupathy S, Elanchezhiyan C, Vasudevan K, Rajagopal G (2002) Antiatherogenic effect of taurine in high fat diet fed rats. Indian J Exp Biol 40:1169–1172PubMed
35.
Zurück zum Zitat Murakami S, Kondo Y, Nagate T (2000) Effect of long-term treatment with taurine in mice fed a high-fat diet: improvement in cholesterol metabolism and vascular lipid accumulation by taurine. Adv Exp Med Biol 483:177–186PubMedCrossRef Murakami S, Kondo Y, Nagate T (2000) Effect of long-term treatment with taurine in mice fed a high-fat diet: improvement in cholesterol metabolism and vascular lipid accumulation by taurine. Adv Exp Med Biol 483:177–186PubMedCrossRef
36.
Zurück zum Zitat Balkan J, Kanbagli O, Hatipoglu A, et al. (2002) Improving effect of dietary taurine supplementation on the oxidative stress and lipid levels in the plasma, liver and aorta of rabbits fed on a high-cholesterol diet. Biosci Biotechnol Biochem 66:1755–1758CrossRefPubMed Balkan J, Kanbagli O, Hatipoglu A, et al. (2002) Improving effect of dietary taurine supplementation on the oxidative stress and lipid levels in the plasma, liver and aorta of rabbits fed on a high-cholesterol diet. Biosci Biotechnol Biochem 66:1755–1758CrossRefPubMed
37.
Zurück zum Zitat Park T, Lee K (1998) Dietary taurine supplementation reduces plasma and liver cholesterol and triglyceride levels in rats fed a high-cholesterol or a cholesterol-free diet. Adv Exp Med Biol 442:319–325PubMed Park T, Lee K (1998) Dietary taurine supplementation reduces plasma and liver cholesterol and triglyceride levels in rats fed a high-cholesterol or a cholesterol-free diet. Adv Exp Med Biol 442:319–325PubMed
38.
Zurück zum Zitat Yokogoshi H, Oda H (2002) Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. Amino Acids 23:433–439CrossRefPubMed Yokogoshi H, Oda H (2002) Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. Amino Acids 23:433–439CrossRefPubMed
39.
Zurück zum Zitat Murakami S, Kondo Y, Toda Y, et al. (2002) Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 70:2355–2366CrossRefPubMed Murakami S, Kondo Y, Toda Y, et al. (2002) Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 70:2355–2366CrossRefPubMed
40.
Zurück zum Zitat Murakami S, Kondo OY, Tomisawa K (1999) Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci 64:83–91CrossRefPubMed Murakami S, Kondo OY, Tomisawa K (1999) Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci 64:83–91CrossRefPubMed
41.
Zurück zum Zitat Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 280:E827–E847PubMed Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 280:E827–E847PubMed
42.
Zurück zum Zitat Bajaj M, Suraamornkul S, Piper P, et al. (2004) Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89:200–206CrossRefPubMed Bajaj M, Suraamornkul S, Piper P, et al. (2004) Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89:200–206CrossRefPubMed
43.
Zurück zum Zitat Kaser S, Moschen A, Cayon A, et al. (2005) Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 54:117–121CrossRefPubMed Kaser S, Moschen A, Cayon A, et al. (2005) Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 54:117–121CrossRefPubMed
44.
Zurück zum Zitat Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91–100CrossRefPubMed Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91–100CrossRefPubMed
45.
Zurück zum Zitat Wang WY (1995) Intestinal endotoxin translocation in endotoxemic rats. Sheng Li Ke Xue Jin Zhan 26:41–44PubMed Wang WY (1995) Intestinal endotoxin translocation in endotoxemic rats. Sheng Li Ke Xue Jin Zhan 26:41–44PubMed
46.
Zurück zum Zitat Reeves HL, Friedman SL (2002) Activation of hepatic stellate cells—a key issue in liver fibrosis. Front Biosci 7:D808–D826PubMed Reeves HL, Friedman SL (2002) Activation of hepatic stellate cells—a key issue in liver fibrosis. Front Biosci 7:D808–D826PubMed
47.
Zurück zum Zitat Wu J, Zern MA (2000) Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 35:665–672CrossRefPubMed Wu J, Zern MA (2000) Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 35:665–672CrossRefPubMed
48.
Zurück zum Zitat Yata Y, Gotwals P, Koteliansky V, Rockey DC (2002) Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy. Hepatology 35:1022–1030CrossRefPubMed Yata Y, Gotwals P, Koteliansky V, Rockey DC (2002) Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy. Hepatology 35:1022–1030CrossRefPubMed
49.
Zurück zum Zitat Tahashi Y, Matsuzaki K, Date M, et al. (2002) Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35:49–61CrossRef Tahashi Y, Matsuzaki K, Date M, et al. (2002) Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35:49–61CrossRef
50.
Zurück zum Zitat Chen Y, Li S, Zhang X (1999) Taurine inhibits deposition of extracellular matrix in experimental liver fibrosis in rats. Zhonghua Gan Zang Bing Za Zhi 7:165–167PubMed Chen Y, Li S, Zhang X (1999) Taurine inhibits deposition of extracellular matrix in experimental liver fibrosis in rats. Zhonghua Gan Zang Bing Za Zhi 7:165–167PubMed
51.
Zurück zum Zitat Chen YX, Zhang XR, Xie WF, Li S (2004) Effect of taurine on proliferation and apoptosis of hepatic stellate cells in vitro. Hepatobiliary Pancreat Dis Int 3:106–109PubMed Chen YX, Zhang XR, Xie WF, Li S (2004) Effect of taurine on proliferation and apoptosis of hepatic stellate cells in vitro. Hepatobiliary Pancreat Dis Int 3:106–109PubMed
Metadaten
Titel
The Restorative Effect of Taurine on Experimental Nonalcoholic Steatohepatitis
Publikationsdatum
01.12.2006
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2006
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9359-y

Weitere Artikel der Ausgabe 12/2006

Digestive Diseases and Sciences 12/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.